Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine (50 page)

BOOK: Pocket Medicine: The Massachusetts General Hospital Handbook of Internal Medicine
5.39Mb size Format: txt, pdf, ePub
liver bx shows characteristic PAS
cytoplasmic inclusion bodies
• Treatment: standard Rx for cirrhosis/chronic liver dis.; ɑ
1
-AT replacement for emphysema
Primary biliary cirrhosis (PBC)
(
Hepatology
2009;50:291;
Lancet
2011;377:1600)
• Autoimmune destruction of
intrahepatic
bile ducts; may be triggered by certain infxns or toxins; a/w X monosomy, variants in IL12ɑ & IL12 receptor genes (
NEJM
2009;360:2544) • Epi:
40–60 y/o; a/w Sjögren’s, Raynaud’s, scleroderma, celiac & thyroid disease • Sx (late): fatigue, pruritus, jaundice, steatorrhea, xanthelasma, autonomic & cog dysfxn • Ddx: PSC, autoimmune hepatitis (overlap syndrome), sarcoid, meds, idiopathic adult ductopenia, biliary stricture/cancer • Dx: ↑ AΦ, ↑ bili, ↑ IgM, ↑ chol,
antimitochondrial Ab (AMA) in 95%. If
AMA, liver bx not needed due to high Se & Sp. 0.5% gen pop
AMA & nl LFTs → 10% develop PBC at 6 y. If AMA
, liver bx (Pts often
ANA, smooth muscle Ab; same prognosis as
AMA).

Rx: ursodeoxycholic acid
(13–15 mg/kg/d) regardless of stage
~25% complete response, ↑ survival & ↓ histologic change & complications (eg, varices) (
Gastro
2005;128:297). Trials of colchicine, MTX, budesonide if refractory to urso.
Pruritus: cholestyramine (give 2–4 h after UDCA); if refractory sx: naltrexone, rifampin
Fat-soluble vitamins; screen/Rx osteoporosis (risk independent of vit Δ deficiency)
If ESLD: liver tx: ~20% recur but no impact on long-term survival

Primary sclerosing cholangitis (PSC)
(
Liver Transpl
2008;14:735)
• Diffuse inflammation of
intrahepatic and extrahepatic
bile ducts leading to fibrosis & stricturing of biliary system. A/w HLA-B8 and -DR3 or -DR4, frequent
autoantibodies but poor response to immunomodulator Rx suggesting nonautoimmune pathogenesis.

• Epi:
>
(20–50 y). ~70% of Pts w/ PSC have IBD (usually UC); only 1–4% w/ UC get PSC.
• Clinical sx: fatigue, pruritus, jaundice, fevers, RUQ pain, cholangioca., ↑ Tb, ↑ AΦ
• Ddx: extrahepatic obstruction, PBC, may also have overlap w/ AIH and similar presentation to IgG4 autoimmune cholangitis (steroid responsive) (
Gastro
2008;134:706) • Dx: MRCP ± ERCP →
multifocal beaded bile duct strictures
, but may miss dx if confined to small intrahepatic ducts (~2% “small duct PSC”: better prognosis,? different disease). Liver bx may show “onion-skin” fibrosis around bile ducts, but not necessary for dx, plays role in excluding autoimmune sclerosing cholangitis.
• Treatment: supportive care, fat-soluble vitamins; no meds have improved survival Ursodeoxycholic acid may ↓ colon CA risk in Pts w/ UC & improve LFTs in Pts w/o UC Dominant stricture: endoscopic dilation, short-term stenting or surgical resection Cholangiocarcinoma (20%): ? biannual surveillance w/ MRCP/RUQ U/S and CA19-9 Liver transplantation: ~30% recurrence, though if UC, colectomy may ↓ recurrence

Other books

A Brig of War by Richard Woodman
Crow Boy by Maureen Bush
Space Invaders by Amber Kell
Angel's Honor by Erin M. Leaf
Hard Eight by Janet Evanovich
Rocky Point Reunion by Barbara McMahon